U.S. Water Utilities Stock News

NasdaqGS:SWKS
NasdaqGS:SWKSSemiconductor

Is Skyworks Solutions (SWKS) Pricing Reflect A 5 Year Slide And Semiconductor Sector Attention

If you are wondering whether Skyworks Solutions is a bargain or a value trap at around US$59.67, this article focuses squarely on what the current price might imply about the company. The stock has returned 2.1% over the last 7 days, while the 1 year return is a 32.8% decline and the 5 year return is a 57.5% decline, which may change how investors think about its risk and potential reward. Recent attention on Skyworks Solutions has been shaped by broader interest in semiconductor stocks and...
NasdaqGS:TRMB
NasdaqGS:TRMBSoftware

Assessing Trimble (TRMB) Valuation As CEO Share Sale Precedes Earnings And Earnings Growth Expectations

Why Trimble’s Upcoming Earnings Are Back in Focus Trimble (TRMB) is back on investors’ radar after its CEO sold a substantial block of shares ahead of the upcoming quarterly earnings release, a timing twist that has sharpened attention on the next results. See our latest analysis for Trimble. Trimble’s share price has been under pressure in recent weeks, with a 7 day share price return of 9.02% and a 30 day share price return of 11.21%. However, the 3 year total shareholder return of 24.94%...
NasdaqGS:EXPO
NasdaqGS:EXPOProfessional Services

What Exponent (EXPO)'s Insider Stock Moves After a Strong Q3 Means For Shareholders

Earlier this week, Exponent President and CEO Catherine Corrigan sold US$120,593 of EXPO shares while exercising options to acquire additional stock, shortly after the company reported third-quarter results that exceeded earnings and revenue expectations. The combination of management’s active equity transactions, stronger-than-expected quarterly performance, and supportive analyst commentary is reshaping how investors assess Exponent’s business momentum. We’ll examine how Exponent’s...
NasdaqGS:LEGN
NasdaqGS:LEGNBiotechs

Could New FDA MRD Guidance Quietly Redefine Legend Biotech’s (LEGN) Multiple Myeloma Ambitions?

The FDA recently issued draft guidance endorsing minimal residual disease negativity and complete response rates as accelerated approval benchmarks in multiple myeloma, a framework that directly supports Legend Biotech’s existing trial design for its CAR-T therapy CARVYKTI in earlier treatment lines. This alignment between regulator expectations and Legend Biotech’s CARTITUDE program could streamline its development path and heighten the therapy’s profile in frontline myeloma care. With this...
NYSE:CRL
NYSE:CRLLife Sciences

A Look At Charles River Laboratories (CRL) Valuation After Recent Share Price Momentum

Recent performance snapshot and what it might mean for investors Charles River Laboratories International (CRL) has drawn investor attention after recent trading, with the stock closing at $224.03 and showing mixed short term moves alongside stronger returns over the past year. Over the past month, the stock return is 10.43%. The past 3 months show a 13.70% gain, and the 1 year total return stands at 34.26%. Short term performance is more muted, with a 0.25% move over the past week and a...
NYSE:ZTO
NYSE:ZTOLogistics

ZTO Express Shifts To Quality Led Growth After Volume Leadership Run

ZTO Express (Cayman) set out a new quality led growth plan at its 2026 National Network Conference. The company highlighted priorities around operational safety, service upgrades, and network optimization. The update follows a decade of industry leadership and expansion in parcel and reverse logistics volumes. For investors watching NYSE:ZTO, the new roadmap arrives with the stock at $22.32 and a 25.1% gain over the past year. Over a 3 year and 5 year span, returns of 16.3% and 24.8%...
NYSE:NJR
NYSE:NJRGas Utilities

Is New Jersey Resources (NJR) Pricing Look Justified After Steady Multi‑Year Share Gains

If you are wondering whether New Jersey Resources is fairly priced or offering value right now, it helps to start with how the market has been treating the stock recently. New Jersey Resources shares last closed at US$48.33, with returns of 1.6% over 7 days, 4.7% over 30 days, 5.1% year to date, 7.8% over 1 year, 9.3% over 3 years, and 66.0% over 5 years. This gives a useful backdrop before comparing price to fundamentals. Recent coverage around New Jersey Resources has focused on the...
NYSE:VG
NYSE:VGOil and Gas

Venture Global Arbitration Win And LNG Stock Valuation In Focus

Venture Global, NYSE:VG, recently secured an arbitration win against Repsol in a dispute over LNG supply contracts. The ruling comes while the company remains in separate contractual disagreements with BP and Shell. This outcome adds a new legal reference point in ongoing LNG contract discussions involving major energy buyers. For investors tracking Venture Global, the arbitration result arrives with the stock at $9.53 and recent returns of 19.7% over the past week and 35.6% over the past...
NYSE:HGTY
NYSE:HGTYInsurance

Will Hagerty’s (HGTY) Paris Collector Car Push Reshape Its Global Enthusiast Ecosystem Narrative?

Broad Arrow Auctions, a Hagerty company, recently held live public previews of its Global Icons Online Auction series and the Concorso d’Eleganza Villa d’Este Auction at iconic Paris venues during Rétromobile car week, showcasing rare collector cars such as Michael Schumacher’s 1992 Benetton B192 Formula One car and the Type 18 Bugatti “Black Bess.” This high-profile presence in Paris underlines Hagerty’s push to deepen its role in the global collector car ecosystem and strengthen brand...
NasdaqGS:GTLB
NasdaqGS:GTLBSoftware

Is GitLab’s (GTLB) Agentic AI Push Reframing Its Long‑Term DevOps Platform Ambitions?

In mid-January 2026, GitLab Inc. launched the GitLab Duo Agent Platform into general availability, introducing Agentic Chat, prebuilt and custom AI agents, and a GitLab Credits system that enables usage-based access to these tools for Premium and Ultimate subscribers across GitLab.com, Self-Managed, and Dedicated deployments. The release directly targets the so‑called AI paradox in software delivery by extending AI beyond code generation into planning, security, compliance, and CI/CD...
NasdaqGS:ACIW
NasdaqGS:ACIWSoftware

Is ACIW’s Leadership Shift And $500 Million Buyback Altering The Investment Case For ACI Worldwide (ACIW)?

Earlier in January 2026, ACI Worldwide announced that Chief Technology Officer Abe Kuruvilla would depart on January 15, 2026, with Chief Innovation and Technology Officer JP Krishnamoorthy assuming his responsibilities. This leadership change comes as ACI Worldwide is emphasizing growth in its cloud-native payments platforms and expanding its share repurchase authorization to US$500,000,000. Against this backdrop, we will explore how the expanded US$500,000,000 share repurchase...
NYSE:ALK
NYSE:ALKAirlines

Alaska Air Faces Bearish Thesis On Loyalty Security Governance And Earnings

Bearish commentary has emerged around Alaska Air Group’s loyalty program and technology controls, pointing to repeated customer account hacks and alleged weak responses to security incidents. Critics are also raising questions about certain accounting practices and broader governance oversight at Alaska Air Group. These concerns introduce the risk of operational disruption, legal pressure, and reputational damage for Alaska Air Group, which trades on the NYSE under ticker NYSE:ALK with a...
NasdaqGS:VC
NasdaqGS:VCAuto Components

Visteon TomTom AI Assistant Puts cockpit Electronics And Valuation In Focus

Visteon (NasdaqGS:VC) has partnered with TomTom to launch what they describe as the world's first in car local AI conversational navigation assistant. The solution combines Visteon's in car AI platform with TomTom's navigation technology to enable natural language interaction and hybrid offline and online functionality. The collaboration also targets electric vehicles with features tailored to EV driving and charging needs, while keeping user data processed locally for privacy. Visteon,...
NYSE:UNFI
NYSE:UNFIConsumer Retailing

Legal Scrutiny And Governance Questions For Undervalued United Natural Foods

Ongoing investigation by Kahn Swick & Foti, LLC into potential breaches of fiduciary duty by officers and directors of United Natural Foods, Inc. (NYSE:UNFI). A securities class action lawsuit tied to these issues is progressing in court after recent decisions allowed the case to move forward. The legal developments highlight governance and disclosure questions that could be material for current and prospective shareholders. United Natural Foods, Inc. (NYSE:UNFI) operates as a distributor...
NYSE:OSK
NYSE:OSKMachinery

Oshkosh (OSK) Valuation Check After New U.S. Army FMTV A2 Arctic Vehicle Contract

Oshkosh (OSK) is back in focus after its defense unit secured a U.S. Army contract for 97 additional FMTV A2 LVAD vehicles equipped for extreme cold, highlighting continuing military demand. See our latest analysis for Oshkosh. The latest Army order lands as Oshkosh’s share price trades at about $156.60, with a 30 day share price return of 19.48% and year to date share price return of 18.44%. This points to building momentum alongside a 1 year total shareholder return of 65.67%. If this kind...
NYSE:PGR
NYSE:PGRInsurance

Is Progressive (PGR) Still Attractive After Recent Share Price Pullback?

If you are wondering whether Progressive's share price still reflects its true worth, the starting point is understanding how its current market price lines up with different valuation checks. The stock last closed at US$206.92, with returns of 1.7% over the past week, a 9.2% decline over the last 30 days, a 2.5% decline year to date, an 8.0% decline over 1 year, a 67.9% gain over 3 years and a 161.7% gain over 5 years. Recent news around Progressive has focused on its position in the US...
NYSE:LEU
NYSE:LEUOil and Gas

Is It Too Late To Consider Centrus Energy (LEU) After Its 221% One-Year Surge?

If you are wondering whether Centrus Energy at US$302.37 is still good value after such a strong run, you are not alone. The share price shows a 1.2% decline over the last 7 days, a 17.2% gain over 30 days, 11.0% year to date, 221.0% over 1 year, and a very large return over 3 and 5 years. Recent coverage of Centrus Energy has focused on its role as a uranium enrichment player at a time when interest in nuclear related companies has been rising again. This backdrop helps explain why the...
NasdaqGS:CRUS
NasdaqGS:CRUSSemiconductor

Is Cirrus Logic’s (CRUS) Mixed-Signal Expansion and Buybacks Quietly Rewriting Its Investment Story?

Cirrus Logic recently highlighted improving business fundamentals, emphasizing robust demand for its mixed-signal components in smartphones alongside growing adoption in PCs, automotive, industrial, and professional audio markets. The company underscored its plan to expand its mixed-signal addressable market while seeking to enhance shareholder value through ongoing share repurchase activity. We’ll now explore how Cirrus Logic’s mixed-signal diversification push could influence the company’s...
NYSE:FCX
NYSE:FCXMetals and Mining

Freeport McMoRan (FCX) Net Margin Improvement Tests Premium P/E And Undervaluation Narrative

Freeport-McMoRan (FCX) has wrapped up FY 2025 with Q4 revenue of US$5,633 million and basic EPS of US$0.28, rounding out a trailing twelve month profile that includes US$25.9 billion in revenue and EPS of US$1.53. Over the past year, the company has seen quarterly revenue move between US$5,633 million and US$7,582 million, while basic EPS has ranged from US$0.24 to US$0.53. This gives investors a clearer view of how earnings tracked through the cycle. With a trailing net profit margin of 8.5%...
NYSE:QXO
NYSE:QXOTrade Distributors

A Look At QXO (QXO) Valuation After Its US$753.2m Follow On Equity Offering

QXO (QXO) has just completed a follow on equity offering of about US$753.2m in common stock, issuing 31,645,570 shares at US$23.80 each, a US$0.10 per share discount. See our latest analysis for QXO. The follow on deal comes after a strong run in the stock, with a 30 day share price return of 11.46% and a 90 day share price return of 31.16%. The 1 year total shareholder return of 72.53% suggests momentum has been building over a longer stretch. If QXO's latest capital raise has you thinking...
NasdaqGM:EXPI
NasdaqGM:EXPIReal Estate

A Look At eXp World Holdings (EXPI) Valuation After Delaware Court Lets Oversight Lawsuit Proceed

The Delaware Court of Chancery’s decision to let a derivative suit over alleged oversight failures on sexual misconduct proceed against eXp World Holdings (EXPI) has put the company’s governance and risk controls under closer investor scrutiny. See our latest analysis for eXp World Holdings. At a share price of $9.35, eXp World Holdings has a modest 1-day and 7-day share price return, a 90-day share price return of 17.48% decline, and a 1-year total shareholder return of 13.76% loss. This...
NYSE:BRBR
NYSE:BRBRPersonal Products

Coca Cola Protein Endorsement Reframes BellRing Brands Valuation And Risks

Coca-Cola's CEO recently highlighted strong consumer interest in protein beverages, calling out the category as a key growth area. This comment directly supports the sector outlook for BellRing Brands (NYSE:BRBR), which owns Premier Protein and Dymatize. The endorsement arrives after investor questions around inventory levels and demand softness in ready to drink and powder protein products. For you as an NYSE:BRBR watcher, the Coca-Cola CEO's remarks offer fresh outside confirmation that...
NYSE:IBP
NYSE:IBPConsumer Durables

Installed Building Products (IBP) Valuation Check After Debt Refinancing And Expanded Lending Facility

Installed Building Products (IBP) has just completed a $500 million senior unsecured notes offering and expanded its asset-based lending facility to $375 million, reshaping its debt profile and widening available liquidity for future choices. See our latest analysis for Installed Building Products. The refinancing news lands after a strong run in the shares, with a 15.14% 1 month share price return and a 13.83% year to date share price return. The 1 year total shareholder return of 50.87%...
NYSE:BIO
NYSE:BIOLife Sciences

Is Bio-Rad Laboratories (BIO) Starting To Look Attractive After Prolonged Share Price Weakness?

Wondering if Bio-Rad Laboratories at around US$305 a share is starting to look like value, or if the recent price action is a warning sign you should not ignore? The stock has been volatile, with a 5.2% decline over the last week, a 1.4% gain over the past month, and longer term returns of a 13.4% decline over 1 year, 35.9% decline over 3 years, and 46.1% decline over 5 years. These moves sit against a backdrop of ongoing interest in life sciences and diagnostics. In this space, investors...